Dr Hopkins is an experienced pharmaceutical executive with over 11 years in corporate leadership roles. He has an established track record in the development of novel cancer therapies with a particular focus on corporate strategy, business development and intellectual property.Dr Hopkins was a co-founder of Phylogica, where, in addition to the CEO role, he served in a variety of positions, including Chief Scientific Officer, VP Research and Chief Operating Officer where he led a team of over 25 scientists. Dr Hopkins established programs that resulted in strategic alliances and licensing deals with multiple global pharmaceutical partners (Pfizer, MedImmune, Roche, Genentech, Janssen, Phoremost) that generated over $10 million in revenues and built a strong proprietary pipeline.
Dr Hopkins is the author of over 25 peer-reviewed publications and is an inventor on 17 patents and patent applications. Dr Hopkins currently serves as Chair of the Western Australian Ausbiotech Committee.